Standardising Care and Treatment of Transthyretin Amyloid Cardiomyopathy

Transthyretin cardiac amyloidosis (ATTR-CA) has been traditionally considered a rare and inexorably fatal condition. ATTR-CA now is an increasingly recognised cause of heart failure and mortality worldwide with effective pharmacological treatments. Advances in non-invasive diagnosis, coupled with th...

Descripción completa

Detalles Bibliográficos
Autores principales: Fontana, Marianna, Porcari, Aldostefano, Hawkins, Philip N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ubiquity Press 2023
Materias:
Invited Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668877/
https://www.ncbi.nlm.nih.gov/pubmed/38028963
http://dx.doi.org/10.5334/gh.1275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668877/
https://www.ncbi.nlm.nih.gov/pubmed/38028963
http://dx.doi.org/10.5334/gh.1275

Ejemplares similares